Elicera Therapeutics (Sweden) Analysis
| ELIC Stock | 1.89 0.15 8.62% |
Elicera Therapeutics AB is overvalued with Real Value of 1.51 and Hype Value of 1.89. The main objective of Elicera Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Elicera Therapeutics AB is worth, separate from its market price. There are two main types of Elicera Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Elicera Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Elicera Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Elicera Therapeutics stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Elicera Therapeutics is usually not traded on All Saints ' Day, St . John 's Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay. Elicera Stock trading window is adjusted to Europe/Stockholm timezone.
Elicera |
Elicera Stock Analysis Notes
About 63.0% of the company shares are held by company insiders. The book value of Elicera Therapeutics was currently reported as 1.86. The company recorded a loss per share of 0.86. Elicera Therapeutics had not issued any dividends in recent years. To learn more about Elicera Therapeutics AB call Jamal MSc at 46 7 03 31 90 51 or check out https://www.elicera.com.Elicera Therapeutics Investment Alerts
| Elicera Therapeutics may become a speculative penny stock | |
| Elicera Therapeutics had very high historical volatility over the last 90 days | |
| Elicera Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 587. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 587. | |
| Elicera Therapeutics generates negative cash flow from operations | |
| About 63.0% of the company shares are held by company insiders |
Elicera Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elicera Therapeutics's market, we take the total number of its shares issued and multiply it by Elicera Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 5th of January, Elicera Therapeutics shows the Coefficient Of Variation of 1017.45, mean deviation of 3.52, and Downside Deviation of 3.45. Elicera Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Elicera Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Elicera Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Elicera Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Elicera Therapeutics Outstanding Bonds
Elicera Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elicera Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elicera bonds can be classified according to their maturity, which is the date when Elicera Therapeutics AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Elicera Therapeutics Predictive Daily Indicators
Elicera Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elicera Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Elicera Therapeutics Forecast Models
Elicera Therapeutics' time-series forecasting models are one of many Elicera Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elicera Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Elicera Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Tools for Elicera Stock Analysis
When running Elicera Therapeutics' price analysis, check to measure Elicera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicera Therapeutics is operating at the current time. Most of Elicera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicera Therapeutics' price. Additionally, you may evaluate how the addition of Elicera Therapeutics to your portfolios can decrease your overall portfolio volatility.